Detect Early, Act Early: Improving Diagnosis of Type 1 Diabetes

Type 1 diabetes affects more than 9 million people worldwide and delayed diagnosis can have life-threatening consequences. Could early screening change the future of this autoimmune condition? While genetic and environmental factors contribute to risk, there is currently no way to prevent its onset. However, advances in screening and therapeutic research are opening new possibilities for earlier detection and intervention. This online event, organised by the International Diabetes Federation (IDF), explores the importance of screening for islet autoantibodies and identify people at risk for type 1 diabetes years before symptoms appear. During this webinar, IDF officially launches the new IDF–ISPAD Policy Brief on Detect Early, Act Early: Improving Diagnosis of Type 1 Diabetes. Developed in collaboration with the International Society for Pediatric and Adolescent Diabetes (ISPAD), the policy brief outlines evidence-based recommendations to support early identification strategies, reduce the risk of diabetic ketoacidosis at diagnosis, and advance prevention-focused approaches worldwide. Download the policy brief: https://idf.org/what-we-do/advocacy/r... //Experts discuss: -- The global burden of type 1 diabetes -- The risks of delayed diagnosis -- The role of islet autoantibody screening -- Community-based education and screening programmes - Barriers to universal screening in low and middle-income countries -- New therapies that may delay the onset of type 1 diabetes -- Key recommendations from the new IDF-ISPAD policy brief As scientific progress continues, screening and early identification may transform how we manage and potentially delay the onset of type 1 diabetes. ----------------------------------------------------------------------------------------------- 00:00 - Welcome and opening remarks, Ana Álvarez Pagola, moderator 04:02 - Message from Prof Peter Schwarz, President, International Diabetes Federation 07:11 - Message from Prof Fergus Cameron, President, International Society for Pediatric and Adolescent Diabetes 09:46 - Prof Jennifer Couper on the key messages of the policy brief 19:51 - Lucia Feito Allonca and Nkiruka Okoro present a summary of their stories and the policy recommendations 33:41 - John Story shares his story and the Lyla's Law campaign 41:28 - Discussion panel with Prof Jennifer Couper, Lucia Feito Allonca, Nkiruka Okoro and Anita Sabidi 01:21:05 - Closing reflections and thanks ---------------------------------------------------------------------------------------------- // SUBSCRIBE to our YouTube channel: @IntDiabetesFed // RECEIVE IDF e-alerts: https://idf.org/ // FOLLOW US on social media & stay updated on our activities: FACEBOOK:   / intdiabetesfed   INSTAGRAM:   / intdiabetesfed   X: https://x.com/IntDiabetesFed LINKEDIN:   / international-diabetes-federation   TIKTOK:   / intdiabetesfed   #Type1Diabetes #DiabetesScreening #AutoimmuneDisease #PublicHealth #IDF #ISPAD #GlobalHealth #EarlyDetection